Vivos (RDGL) Cash & Current Investments (2010 - 2025)
Vivos recorded quarterly Cash & Current Investments of $1.6 million in Q4 2025, down 29.23% quarter-over-quarter from $2.2 million in Q3 2025, and down 29.56% year-over-year from $2.2 million in Q4 2024.
Vivos' Cash & Current Investments history runs 16 years deep, the most recent figure standing at $1.6 million for Q4 2025.
- In Q4 2025, Cash & Current Investments fell 29.56% year-over-year to $1.6 million; the TTM figure through Dec 2025 stood at $1.6 million (down 29.56% YoY), while the FY2025 annual figure was $1.6 million, down 29.56% from the prior year.
- Cash & Current Investments came in at $1.6 million for Q4 2025 at Vivos, down from $2.2 million in the prior quarter.
- In the past five years, Cash & Current Investments ranged from a high of $3.3 million in Q1 2025 to a low of $1.1 million in Q2 2022.
- A 5-year average of $1.8 million and a median of $1.7 million in 2022 frame the typical range for Cash & Current Investments.
- Across the five-year window, Cash & Current Investments soared 13202.47% in 2021 and sank 51.46% in 2022, its largest moves.
- Vivos' Cash & Current Investments stood at $1.6 million in 2021, then increased by 6.22% to $1.7 million in 2022, then slipped by 6.67% to $1.6 million in 2023, then soared by 38.95% to $2.2 million in 2024, then slipped by 29.56% to $1.6 million in 2025.
- According to Business Quant data, Cash & Current Investments over the past three periods registered $1.6 million, $2.2 million, and $2.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 7.30 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 2.88 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 8.38 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.45 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 3.67 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 3.12 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 1.12 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 2.29 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 439.60 Mn |
| 10 | Vivos | - | - | -3,105.00 | 1.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.56 Mn |
| Sep 30, 2025 | 2.20 Mn |
| Jun 30, 2025 | 2.66 Mn |
| Mar 31, 2025 | 3.27 Mn |
| Dec 31, 2024 | 2.21 Mn |
| Sep 30, 2024 | 1.22 Mn |
| Jun 30, 2024 | 1.72 Mn |
| Mar 31, 2024 | 1.37 Mn |
| Dec 31, 2023 | 1.59 Mn |
| Sep 30, 2023 | 1.54 Mn |
| Jun 30, 2023 | 1.75 Mn |
| Mar 31, 2023 | 1.41 Mn |
| Dec 31, 2022 | 1.71 Mn |
| Sep 30, 2022 | 1.99 Mn |
| Jun 30, 2022 | 1.05 Mn |
| Mar 31, 2022 | 1.22 Mn |
| Dec 31, 2021 | 1.61 Mn |
| Sep 30, 2021 | 1.99 Mn |
| Jun 30, 2021 | 2.16 Mn |
| Mar 31, 2021 | 2.51 Mn |
| Dec 31, 2020 | 903,704.00 |
| Sep 30, 2020 | 14,934.00 |
| Jun 30, 2020 | 248,855.00 |
| Dec 31, 2019 | 20,381.00 |
| Sep 30, 2019 | 158,538.00 |
| Jun 30, 2019 | 8,502.00 |
| Mar 31, 2019 | 41,789.00 |
| Dec 31, 2018 | 5,494.00 |
| Mar 31, 2018 | 16.00 |
| Dec 31, 2017 | 8,317.00 |
| Sep 30, 2017 | 22,110.00 |
| Jun 30, 2017 | 369,449.00 |
| Mar 31, 2017 | 23,700.00 |
| Dec 31, 2016 | 27,889.00 |
| Sep 30, 2016 | 15.00 |
| Jun 30, 2016 | 183.00 |
| Mar 31, 2016 | 247,937.00 |
| Dec 31, 2015 | 179,032.00 |
| Sep 30, 2015 | 7,396.00 |
| Jun 30, 2015 | 26,231.00 |
| Mar 31, 2015 | 2,485.00 |
| Dec 31, 2014 | 203.00 |
| Sep 30, 2014 | 1,525.00 |
| Jun 30, 2014 | 126,242.00 |
| Mar 31, 2014 | 91,641.00 |
| Sep 30, 2013 | 26,221.00 |
| Jun 30, 2013 | 6,986.00 |
| Mar 31, 2013 | 67,521.00 |
| Dec 31, 2012 | 6,411.00 |
| Sep 30, 2012 | 47,381.00 |
| Jun 30, 2012 | 13,843.00 |
| Dec 31, 2011 | 52,557.00 |
| Sep 30, 2011 | 18,652.00 |
| Jun 30, 2011 | 5,132.00 |
| Dec 31, 2010 | 589,390.00 |
| Sep 30, 2010 | 555,991.00 |
| Jun 30, 2010 | 51,337.00 |